London, United Kingdom
SIME Diagnostics is a clinical AI company founded in 2014 and headquartered in the United Kingdom. The company's slogan "Applying medical excellence, proprietary AI & data ingenuity to deliver rapid respiratory intensive care diagnostics" reflects its focus on leveraging technology for healthcare solutions. SIME is dedicated to addressing acute unmet needs in the healthcare sector with its clinically proven technology, which enables early intervention in life-threatening diseases, leading to improved outcomes and reduced costs.
The latest funding for SIME Diagnostics was a Venture Round investment received on 01 January 2021, with Consilience Ventures being the investing party. As a company operating at the intersection of AI, Data Analytics, Health Care, and Machine Learning, SIME Diagnostics presents an intriguing opportunity for venture capital investors looking to support innovative healthcare technology startups. With its strong focus on rapid respiratory intensive care diagnostics and proprietary AI-driven solutions, SIME Diagnostics has the potential to make a significant impact in the healthcare industry.
